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Abstract
Three finishing experiments were
conducted in commercial feedlots to
determine effects of implant programs on
finishing heifer performance, carcass
characteristics, and economics. A total of
3,307 heifers were used in the three
experiments. Overall, four treatment
comparisons were tested within the three
separate experiments. Treatment groups
included the following:  1) heifers
implanted with Synovex® Plus (Fort
Dodge Animal Health; Fort Dodge, IA)
but not fed melengestrol acetate (MGA®;
Pharmacia and Upjohn Company;
Kalamazoo, MI) , 2) heifers implanted
with Synovex® Plus and fed MGA®, 3)
heifer implanted with Revalor®-H
(Intervet Inc.; Millsboro, DE) and fed
MGA®, and 4) heifers implanted with
Finaplix®-H (Intervet Inc.) and fed
MGA®. Common treatments of Synovex®
Plus and dietary MGA® as well as
Finaplix®-H and dietary MGA® were
used in each of the three experiments.
Finishing heifers fed MGA® and im-
planted with Synovex® Plus had 3.9 and
4.1% greater (P<0.10) ADG than did
heifers implanted with Revalor®-H or
Finaplix®-H and fed MGA®, respectively.
Daily gain did not differ for heifers
implanted with Revalor®-H or Finaplix®-
H. Feeding MGA® to heifers implanted
with Synovex® Plus increased ADG and
decreased deleterious effects on quality
grade; however; carcasses had greater fat
thickness. Fewer carcasses of heifers fed
MGA® and implanted with Synovex®
Plus or Revalor®-H were graded Choice
in comparison with the carcasses of those
implanted with Finaplix®-H. When
selling heifers on a carcass-merit basis,
net returns did not differ among heifers
implanted with Synovex® Plus, Revalor®-
H, or Finaplix®-H when fed MGA®.
When selling heifers on a dressed basis,
net return was maximized (P<0.10) with
the use of Synovex® Plus and supplemen-
tation with MGA® compared with
Synovex® Plus and no MGA® supplemen-
tation, Revalor®-H and MGA® supple-
mentation, and Finaplix®-H and MGA®
supplementation.





widely accepted for use in the finish-
ing phase of beef production to
improve ADG and feed efficiency.
Implants contain a single dose or a
combination dose of active com-
pounds that influence growth of beef
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cattle. Although the exact mecha-
nism is not thoroughly understood,
products containing estrogens,
androgens, or both have been
demonstrated to be efficacious under
a variety of feedlot conditions
(Herschler Et al., 1995). Design of an
implant program for finishing heifers
can be challenging and involves
numerous decisions (level of ingredi-
ents, time of implants, number of
implant times, etc.). Another major
decision involves inclusion of
melengestrol acetate (MGA®;
Pharamacia and Upjohn Company;
Kalamazoo, MI) in the diet.
Melengestrol acetate affects endog-
enous estrogen levels (Henricks et al.,
1997). Combining trenbolone acetate
(TBA) with an estradiol (E2) implant
(Trenkle, 1994) or feeding MGA®
(Montgomery et al., 1992) increased
efficacy of TBA in feedlot heifers.
This relationship has brought prod-
ucts such as Synovex® Plus [Fort
Dodge Animal Health; Fort Dodge,
IA; 28 mg of estradiol benzoate (20
mg E2) and 200 mg of TBA] and
Revalor®-H (Intervet Inc.; Millsboro,
DE; 14 mg of E2 and 140 mg of TBA)
to the market. The use of TBA, as a
single active compound, and supple-
mental MGA® has been a common
practice used by feedlots (Galyean,
1997). Finaplix®-H (Intervet Inc.) is
an implant that contains only 200
mg of TBA. Based on the potential
interactions of exogenous and
endogenous increases of E2, there is
justification for larger replicated
studies involving these sources. The
objectives of these experiments were
1) to compare performance, carcass
characteristics, and feeding econom-
ics in heifers implanted with
Synovex® Plus, Revalor®-H, or
Finaplix®-H as the final implant and
2) to determine whether MGA®
supplementation is beneficial in
finishing heifers implanted with
Synovex® Plus.
Materials and Methods
Experiment 1. The experiment was
conducted in a commercial feedyard
in central Nebraska between Decem-
ber 23 and July 20 using 879 yearling
crossbred beef heifers (330 ± 23 kg) in
a randomized block design. Blocks (n
= 5) were based on arrival date.
Heifers that were used were of Bos
taurus breeds. Within the five blocks
of heifers, one block was predomi-
nately British breeds, one block was
predominately Continental breeds,
and three blocks were British ´
Continental breeds. Heifers arriving
at the feedyard were kept separated
by truckload following unloading
and were weighed. Heifers from the
separate truckloads were assigned
randomly to one of three implant
programs in groups of two heifers by
a gate sort into one of three arrival
pens and then assigned to one of 15
pens (5 pens per treatment). Treat-
ment groups included 1)  heifers
implanted with Synovex® Plus and
fed MGA®, 2) heifers implanted with
Synovex® Plus and not fed MGA®, or
3) heifers implanted with Finaplix®-H
and fed MGA®. The finishing diet
that contained MGA® was formulated
to provide 0.45 mg of MGA®/d per
heifer. Within a block, all heifers
arrived at the feedyard at the same
time. After sorting, heifers (by pen)
were reweighed, processed, and
moved to their home pen. During
processing, heifers were vaccinated
for viral diseases (BoviShield 4®; Pfizer
Inc., New York City, NY), treated for
internal and external parasites
(Dectomax®; Pfizer Inc.), implanted
with Ralgro® (36 mg of zeranol;
Schering-Plough Inc.; New York City,
NY), and given a lot-tag for identifi-
cation. Blocks of heifers were re-
implanted a second time with either
Synovex® Plus or Finaplix®-H, on
average, 90 d (range, 84 to 101 d)
before harvest. Heifers assigned to
Finaplix®-H were fed MGA® following
adaptation to the final diet (18 to 20
d on feed). Additionally, one treat-
ment of heifers implanted with
Synovex® Plus was fed MGA® follow-
ing adaptation to the final diet (18
to 20 d on feed). Blocks of heifers
were fed an average of 150 d; the
range was 128 to 172 d because of
initial BW and frame type of the
different blocks of heifers entering
the feedlot.
Initial BW was determined using
the BW recorded by a pen scale when
the heifers arrived at the feedlot
(entire block) and the BW recorded
by a pen scale after the treatment
groups were sorted. The second BW
record for the treatment group was
used to prorate the entire block
weight to determine the initial BW of
each treatment pen. Final live BW
were determined by a pen scale for a
treatment pen just before shipment
and pencil shrunk 4%. Carcass
weights were also used to determine
final BW by adjusting to a common
dressing percentage of 63% to calcu-
late ADG and feed efficiency on a
carcass-adjusted basis. Dry matter of
the diet was determined from samples
of the ingredients analyzed by a
commercial lab.
All pens within a block were
harvested on the same day at the
same abattoir. Harvest date was
determined by the feedlot manager
based on days on final implant,
cattle performance, estimated fatness,
and ability to market the cattle. Hot
carcass weights were recorded on the
day of harvest. Carcass 12th rib fat
thickness; marbling score; kidney,
pelvic, heart (KPH) fat; longissimus
area; and USDA quality grade were
recorded following a 24- to 36-h chill.
Experiment 2. Experiment 2 was
conducted in the same feedyard as
Experiment 1 between January 11 and
August 3 using 1,558 yearling cross-
bred beef heifers (345 ± 30 kg) in a
randomized block design. Blocks (n =
6) were based on arrival date. Heifers
used were of Bos taurus breeds. Within
the six blocks of heifers, one block
was predominately British breeds,
three blocks were predominately
Continental breeds, and two blocks
were British × Continental type
breeds. Heifers were kept separate by
truckload following unloading and
were weighed. Heifers from the
separate truckloads were assigned
randomly to one of three implant
programs one by one using a gate
sort into one of three arrival pens;
then, heifers were assigned to one of
18 pens (6 pens per treatment).
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TABLE 1. Finishing diet composition (100% DM basis)
Composition Exp. 1 Exp. 2 Exp. 3
Ingredient
Steam-flaked corn 57.0 48.0 —-
Dry-rolled corn 16.9 27.0 79.0
Alfalfa hay 7.5 7.5 7.5
Corn steep liquor 6.5 5.5 9.5
Liquid supplement 5.8 5.8 —-
Dry supplement 1.9 1.9 3.0
Liquid MGA®a  supplement 1.4 1.3 —-
Tallow 3.0 3.0 —-
Micro ingredients —- —- 1.0
Calculated nutrient
DM, % 76.3 77.5 82.3
Crude protein, % 13.6 13.7 13.3
Calcium, % 0.8 0.8 0.8
Potassium, % 0.8 0.8 0.8
Phosphorus, % 0.4 0.4 0.4
aMGA® = Melengestrol acetate (Pharmacia and Upjohn Company, Kalamazoo, MI).
TABLE 2. Effects of implant programs using Synovex® Plus (Fort Dodge Animal Health, Fort Dodge, IA) with or
without MGA® (melengestrol; acetate; Pharmacia and Upjohn Company, Kalamazoo, MI) or Finaplix®-H (Intervet
Inc., Millsboro, DE) with MGA®  supplementation on heifer performance (Exp. 1).
Synovex®  plus Synovex®  plus Finaplix®-H plus
Item no MGA® MGA® MGA® SE
Pens, no. 5 5 5
Heifers, no. 294 292 293
Days on feed 150 150 150
Live performancea
Initial BW, kg 329 327 332 1.4
Final BW, kg 534 537 536 2.7
DMI, kg/d 8.6 8.7 8.7 0.07
ADG, kg 1.37 1.40 1.36 0.01
Gain/feed 0.159 0.161 0.157 0.002
Carcass-adjusted performanceb
Final BW, kg 551 555 548 3.5
ADG, kg/d 1.48c 1.52d 1.45e 0.01
Gain/feed 0.172f 0.174f 0.167g 0.002
aFinal BW shrunk 4%.
bFinal BW calculated as hot carcass weight divided by 0.63 (common dressing percentage).
c,d,eMeans within a row with different superscripts differ (P<0.10).
f,gMeans within a row with different superscripts differ (P<0.05).
reweighed, processed, and moved to
their home pen. During processing,
heifers were vaccinated for viral
diseases (BoviShield 4®), treated for
internal and external parasites
(Dectomax®), implanted with
Ralgro®, and given a lot-tag for
identification.
Heifers were re-implanted with
their respective treatment of
Synovex® Plus, Revalor®-H, or
Finaplix®-H following 45 d (range, 35
to 58 d) on feed. Heifers were exposed
to their final implant for an average
of 95 d across blocks (range, 84 to 108
d). Heifers were fed MGA® following
adaptation to the final diet (18 to 20
d on feed). Heifers were fed an
average of 139 d with a range of 127
to 166 d because of differences in
initial BW and frame type of the
different blocks entering the feedlot.
Initial BW were determined by
prorating each treatment pen’s
weight back to the total of the entire
block of heifers’ weight as in Experi-
ment 1. Final live BW were deter-
mined by a pen scale for a treatment
pen just before shipment and pencil
Treatment groups included: 1) heifers
implanted with Synovex® Plus, 2)
heifers implanted with Revalor®-H, or
3) heifers implanted with Finaplix®-H
at re-implant time.  All treatments
included dietary MGA® supplementa-
tion (0.45 mg of MGA®/d per heifer).
Within a block, all heifers arrived
at the feedyard at the same time.
After sorting, pens of heifers were
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shrunk 4%. Carcass weights were also
used and adjusted to a common
dressing percentage of 63% to calcu-
late ADG and feed efficiency on a
carcass-adjusted basis. Dry matter of
the diet was determined from samples
of the ingredients analyzed by a
commercial lab.
All pens within a block were
harvested on the same day at the
same abattoir. Harvest date was
determined by the feedlot manager
based on days on final implant,
cattle performance, estimated fatness,
and ability to market the cattle. Hot
carcass weights were recorded on the
day of harvest. Carcass 12th rib fat
thickness, marbling score, KPH fat,
longissimus area, and USDA quality
grade were recorded following a 24-
to 48-h chill.
Experiment 3. This experiment
was conducted in eastern Nebraska at
a commercial feedyard between
January 12 and June 26 using 870
yearling British × Continental bred
heifers (376 ± 13 kg) in a randomized
block design. Heifers were blocked by
arrival date into the feedyard. Heifers
were processed on arrival, and a block
(n = 3) was maintained in one large
pen until re-implanting. At re-
implanting, a block of heifers was
allotted randomly to one of two
treatments by sorting individual
heifers at chute-side and then assign-
ing each heifer to one of two pens (3
pens per treatment). Treatments were
Synovex® Plus or Finaplix®-H plus
MGA® supplementation formulated
to provide 0.4 mg/d per heifer. Thus,
if the first heifer received Synovex®
Plus, the second heifer through the
chute would have been implanted
with Finaplix®-H, and so on. Initial
BW was determined on individual
heifers at the time of reprocessing.
Final BW was determined by adjust-
ing hot carcass weight to a common
63% dressing percentage. Dry matter
of the diet was determined from
samples of the ingredients analyzed
by a commercial lab.
All pens within a block were
harvested on the same day at the
same abattoir. Harvest date was
determined by the feedlot manager
based on days on final implant,
cattle performance, and ability to
market the cattle. Hot carcass weights
were recorded on the day of harvest.
Carcass 12th-rib fat thickness, mar-
bling score, KPH fat, longissimus
TABLE 3. Effects of implant programs using Synovex® Plus (Fort Dodge Animal Health, Fort Dodge, IA) with or
without MGA® (melengestrol acetate; Pharmacia and Upjohn Company, Kalamazoo, MI) or Finaplix®-H (Intervet
Inc., Millsboro, DE) with MGA®  supplementation on heifer carcass characteristics (Exp. 1).
Synovex®  plus Synovex®  plus Finaplix®-H plus
Item no MGA® MGA® MGA® SE
Hot carcass weight, kg 347 350 346 1.8
Dressing percentage 65.0a 65.1a 64.6b 0.1
Fat thickness, cm 1.22a 1.38b 1.30c 0.02
Longissimus area, cm2 92.3 90.6 87.5 1.4
KPHd fat, % 2.06 2.08 2.06 0.02
Calculated yield grade 2.44a 2.72b 2.75b 0.07
Yield grade distribution, %
1 30.0e 17.7f 14.6f 4.0
2 47.2 45.3 50.7 3.4
3 19.8 31.3 29.8 3.7
4 and 5 3.0 5.6 5.0 1.1
Marbling scoreg 5.19h 5.47i 5.43i 0.04
Quality grade distribution, %
Prime 1.0 3.5 1.0 0.8
Upper 2/3 Choice 16.3 20.3 18.8 1.3
Low Choice 37.8a 43.3a 52.2b 2.3
≥Low Choice 55.1g 67.1h 72.0h 3.2
Select 44.4d 32.0e 27.6e 2.3
Standard 0.5 0.8 0.4 0.7
Dark cutters, % 2.0 1.3 0.0 0.8
a,b,cMeans within a row with different superscripts differ (P<0.05).
dKPH = Kidney, pelvic, heart.
e,fMeans within a row with different superscripts differ (P<0.10).
gMarbling score: 4.0 = Slight 00, 4.5 = Slight 50, 5.0 = Small 00, 5.5 Small 50, etc.
h,iMeans within a row with different superscripts differ (P<0.01).
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TABLE 5. Effects of implant programs using Synovex® Plus (Fort Dodge Animal Health, Fort Dodge, IA) or
Finaplix®-H (Intervet, Millsboro, DE) with MGA® (melengestrol acetate; Pharmacia and Upjohn Company,
Kalamazoo, MI) supplementation on heifer performance (Exp. 2).
Synovex®  plus Finaplix®-H plus Revalor®-H plus
Item MGA® MGA® MGA® SE
Pens, no. 6 6 6
Heifers, no. 523 516 519
Days on feed 139 139 139
Live performancea
Initial BW, kg 345 345 345 1.4
Final BW, kg 551 546 545 2.3
DMI, kg/d 9.2b 8.8c 9.1b 0.09
ADG, kg 1.48 1.44 1.43 0.05
Gain/feed 0.161 0.163 0.157 0.003
Carcass-adjusted performancef
Final BW, kg 567b 559c 560c 1.9
ADG, kg 1.60d 1.53e 1.54e 0.02
Gain/feed 0.174 0.174 0.169 0.003
aFinal BW shrunk 4%.
b,cMeans within a row with different superscripts differ (P<0.05).
d,eMeans within a row with different superscripts differ (P<0.10).
fFinal BW calculated as hot carcass weight divided by 0.63 (common dressing percentage).
TABLE 4. Economic analysis of using Synovex® Plus (Fort Dodge Animal Health, Fort Dodge, IA) with or without
MGA® (melengestrol acetate; Pharmacia and Upjohn Company, Kalamazoo, MI) or Finaplix®-H (Intervet,
Millsboro, DE) with MGA®  supplementation as final implants in finishing heifers (Exp. 1).
Synovex®  plus Synovex®  plus Finaplix®-H plus
Item no MGA® MGA® MGA® SE
Diet costa, $/100 kg 14.43 14.59 14.59
Cost of feed, $ per heifer 185.78 190.05 189.58 1.4
Total feeding cost,
$ per heifer 195.69 199.96 198.90 1.4
Live cost of gain,
$/100 kg 95.75 95.70 97.84 0.95
Carcass-adjusted cost of
gain, $/100 kg 88.35b 88.17b 91.89c 0.77
Carcass valued, $/100 kg 238.96e 240.79f 242.33g 0.55
Profith, $ per heifer
Live basis 68.35bc 73.97b 58.74c 3.8
Dressed basis 88.19b 92.62b 76.12c 3.0
Carcass-merit basis 69.60e 80.57f 68.02e 3.7
aIncludes feed mark-up.
b,cMeans within a row with different superscripts differ (P<0.05).
dCalculated using a $244/100 kg carcass base price. Discounts = $22, Select; $44, Standard; $33, Yield Grade 4 and 5; and $66,
dark cutter. Premiums = $18, Prime; $7, upper 2/3 Choice; and $7, Yield Grades 1 and 2.
e,f,gMeans within a row with different superscripts differ (P<0.10).
hInitial animal cost = $172/100 kg; animal returns based on $154/100 kg live price, $244/100 kg carcass price, or calculated
carcass value; interest not included.
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muscle area, and USDA quality grade
were recorded following a 36- to 48-h
chill.
In all experiments, data are pre-
sented with dead (1.0% overall) and
chronic (0.4% overall) cattle removed
from the analysis. Feed intake and
total head days were adjusted on a
pen basis 1 d prior to the removal of
the animal from the pen as either
dead or chronic. Finishing diets fed
during the experiments are presented
in Table 1.
Economic Analysis. The economic
influence of the implant treatments
was determined using the diet cost at
the feedyard during the period the
experiment was conducted. The diet
cost used in the analysis includes
feedlot markup in Experiments 1 and
2. In Experiment 3, yardage was
charged on a daily basis. Non-feed
costs (medicine, processing, etc.) were
calculated for each pen of heifers in
the experiment and averaged. This
average non-feed cost was applied to
each pen of heifers for calculation of
cost of gain and net return. Initial
heifer cost was calculated by using
the price of $171.81/100 kg, the
approximate 10-yr average for Ne-
braska (Fuez et al., 2000). Final heifer
value was calculated by using a live
price of $154.19/100 kg of live weight
(10-yr average) (Fuez et al., 2000), a
dressed price of $244.50/100 kg of
carcass weight (10-yr average) (Fuez et
al., 2000), or a carcass-merit price
based on individual heifer carcass
value. Carcass value was calculated
based on USDA quality grade, calcu-
lated yield grade, carcass weight, and
nonconformance (i.e., dark cutters).
A carcass base price of $244.50/100 kg
was used for low Choice, Yield Grade
3 carcasses weighing 249 to 431 kg.
Discounts were calculated as follows:
$22.03 for Select grade, $44.05 for
Standard grade, $66.08 for dark
cutters, and $33.04/100 kg for Yield
Grades 4 and 5. Premiums were
calculated as follows: $17.62 for Prime
grade, $6.61 for upper 2/3 Choice
grade, and $6.61/100 kg for Yield
Grades 1 and 2.
Statistical Analysis.  For the three
experiments, performance, carcass,
and economic data were analyzed as
a randomized block design using
SAS® (SAS Inst. Inc., Cary, NC).
Treatment and block were included in
the model. Least squares means were
separated using the least significance
difference method when a significant
(P<0.10) F test was detected. Data
from common treatments (Synovex®
Plus and MGA® and Finaplix®-H and
MGA® ) across experiments were
pooled and analyzed with PROC
TABLE 6. Effects of implant programs using Synovex® Plus (Fort Dodge Animal Health, Fort Dodge, IA)or
Finaplix®-H (Intervet, Millsboro, DE) with MGA® (melengestrol acetate; Pharmacia and Upjohn Company,
Kalamazoo, MI)   supplementation on heifer carcass characteristics (Exp. 2).
Synovex®  plus Finaplix®-H plus Revalor®-H plus
Item MGA® MGA® MGA® SE
Hot carcass weight, kg 357a 351b 353b 1.2
Dressing percentage 64.8 64.5 64.7 0.1
Fat thickness, cm 1.36 1.37 1.38 0.02
Longissimus area, cm2 93.4c 90.2d 91.8cd 0.67
KPHf fat, % 2.10 2.14 2.09 0.03
Calculated yield grade 2.61 2.74 2.68 0.05
Yield grade distribution, %
1 23.4 16.1 21.9 2.6
2 45.0ab 49.6a 41.6b 2.1
3 26.7 27.9 31.7 2.6
4 and 5 4.8 6.3 4.8 1.4
Marbling scoreg 5.26c 5.48d 5.38e 0.04
Quality grade distribution, %
Prime 1.9 2.8 1.4 0.5
Upper 2/3 Choice 16.1a 24.0b 21.7b 3.2
Low Choice 37.1 40.5 42.4 3.1
≥Low Choice 55.1a 67.3b 65.5b 4.2
Select 41.7c 31.2d 33.1d 2.9
Standard 3.1 1.4 1.4 0.7
Dark cutters, % 1.2 0.0 2.0 0.8
a,bMeans within a row with different superscripts differ (P<0.05).
c,d,eMeans within a row with different superscripts differ (P<0.10).
fKPH = Kidney, pelvic, heart.
gMarbling score: 4.0 = Slight 00, 4.5 = Slight 50, 5.0 = Small 00, 5.5 Small 50, etc.
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MIXED in SAS. Kenward-Roger
degrees of freedom correction was
used in the analysis (Kenward and
Rodger, 1997). Experiment, blocks
nested within experiment, and
experiment by treatment interaction
were considered random effects. In all
experimental analyses, experimental
unit was pen of heifers.
Results and Discussion
Experiment 1. Treatment effects
on finishing heifers’ performance are
shown in Table 2. Overall DMI did
not differ (P=0.52) among treatments.
On a carcass-adjusted basis, heifers
implanted with Synovex® Plus with
or without dietary MGA® gained 4.8
and 2.1% faster (P<0.05) and were 4.3
and 3.2% more efficient (P<0.01)
than those implanted with Finaplix®-
H, respectively. Live performance was
not significantly different; however,
numerical differences in live perfor-
mance tended to be similar to carcass-
adjusted performance. Mader et al.
supplemental MGA®. However, heifers
implanted with TBA and fed MGA®
had 4.7% greater ADG than did
heifers implanted with TBA and not
fed MGA® (Trenkle, 1994).
(1998) reported 7.1% greater ADG for
heifers implanted with Synovex® Plus
than for heifers implanted with 200
mg of TBA (equivalent to Finaplix®-
H). Mader et al. (1998) did not use
TABLE 7. Economic analysis of using Synovex® Plus (Fort Dodge Animal Health, Fort Dodge, IA); Revalor®-H
(Intervet, Millsboro, DE), Finaplix®-H (Intervet Inc.) with MGA® (melengestrol acetate; Pharmacia and Upjohn
Company, Kalamazoo, MI) supplementation as final implants in finishing heifers (Exp. 2).
Synovex®  plus Finaplix®-H plus Revalor®-H plus
Item MGA® MGA® MGA® SE
Diet costa, $/100 kg 14.48 14.48 14.48
Cost of feed, $ per heifer 185.36b 178.27c 183.59b 1.6
Total feeding cost,
$ per heifer 194.24b 187.32c 192.95b 1.6
Live cost of gain,
$/100 kg 94.56 93.30 97.40 1.70
Carcass-adjusted cost of
gain, $/100 kg 87.53 87.78 90.51 1.43
Carcass valued, $/100 kg 236.92b 241.21c 239.25bc 1.10
Profite, $ per heifer
Live basis 62.77 61.73 54.15 5.0
Dressed basis 86.91 81.11 76.42 4.7
Carcass-merit basis 59.90 70.37 58.19 5.3
aIncludes feed mark-up.
b,cMeans within a row with different superscripts differ (P<0.05).
dCalculated using a $244/100 kg carcass base price. Discounts = $22, Select; $44, Standard; $33, Yield Grade 4 and 5; and $66,
dark cutter. Premiums = $18, Prime; $7, upper 2/3 Choice; and $7, Yield Grades 1 and 2.
eInitial animal cost = $172/100 kg; animal returns based on $154/100 kg live price, $244/100 kg carcass price or calculated
carcass value; interest not included.
TABLE 8. Effects of implant programs using Synovex®  Plus (Fort Dodge
Animal Health, Fort Dodge, IA) or Finaplix®-H (Intervet, Millsboro, DE),
with MGA® (melengestrol acetate; Pharmacia and Upjohn Company,
Kalamazoo, MI) supplementation on heifer performance (Exp. 3).
Synovex®  plus Finaplix®-H plus
Item MGA® MGA® SE P
Pens, no. 3 3
Heifers, no. 432 438
Days on feed 107 107
Initial BW, kg 376 375 2.5 0.77
Final BWa, kg 537 529 1.9 0.09
DMI, kg/d 9.82 9.51 0.17 0.32
ADG, kg 1.50 1.44 0.007 0.02
Gain/feed 0.153 0.152 0.003 0.85
aFinal BW calculated as hot carcass weight divided by 0.63 (common dressing
percentage).
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Synovex® Plus and not fed MGA® had
reduced (P<0.05) calculated yield
grades and a greater (P<0.10) percent-
age of carcasses grading Yield Grade 1
compared with those fed MGA® and
implanted with either Synovex® Plus
or Finaplix®-H. Heifers fed MGA® and
implanted with Synovex® Plus had
greater (P<0.01) fat thickness com-
pared with heifers implanted with
Synovex® Plus but not fed MGA® or
those implanted with Finaplix®-H.
Heifers implanted with Finaplix®-H
had greater (P<0.01) fat thickness
measurement compared with heifers
implanted with the Synovex® Plus
but not fed MGA®. The current
experiment supports previous studies
in which supplemental MGA® in the
diets of  finishing heifers increased
fat thickness and yield grade (Nichols
et al., 1996; Lubberstedt et al., 1999).
Longissimus area did not differ
(P>0.13) among treatments.
Marbling scores and the percent-
age of carcasses grading USDA Choice
were less (P<0.01) for heifers im-
planted with Synovex® Plus and not
fed MGA® in comparison with those
implanted with Synovex® Plus and
fed MGA® (Table 3). Marbling scores
In heifers implanted with
Synovex® Plus, those fed MGA® had
greater (P<0.10) carcass-adjusted ADG
but similar feed efficiency to heifers
not fed MGA® (Table 2). Brandt et al.
(1996) reported that supplementa-
tion of MGA® along with Revalor®-H
(combination of E2 and TBA) nu-
merically increased ADG by 1.5%
compared with Revalor®-H-implanted
heifers not fed supplemental MGA®.
Using the combination of Heiferoid®
(20 mg of estradiol benzoate and 200
mg testosterone) and Finaplix®-H
implants to achieve a combination
of E2 and TBA, heifers fed MGA
®
gained 3.0% faster than did heifers
not fed MGA® (Montgomery et al.,
1992).
Dressing percentage was greater
(P<0.05) for heifers that were im-
planted with Synovex® Plus than for
those implanted with Finaplix®-H
(Table 3). Heifers implanted with
TABLE 9. Effects of implant programs using Synovex®  Plus (Fort Dodge
Animal Health, Fort Dodge, IA) or Finaplix®-H (Intervet, Millsboro, DE),
with MGA® (melengestrol acetate; Pharmacia and Upjohn Company,
Kalamazoo, MI) supplementation on heifer carcass characteristics (Exp.
3).
Synovex®  plus Finaplix®-H plus
Item MGA® MGA® SE P
Hot carcass weight, kg 338 333 1.1 0.09
Fat thickness, cm 1.38 1.39 0.04 0.95
Longissimus area, cm2 87.1 86.0 0.27 0.10
KPHa fat, % 0.14 2.47 2.52 0.01
Calculated yield grade 2.87 2.90 0.05 0.76
Yield grade distribution, %
1 10.0 12.0 3.2 0.72
2 49.0 41.9 2.8 0.22
3 33.7 38.6 2.4 0.27
4 and 5 7.3 7.6 1.5 0.89
Marbling scoreb 5.65 5.69 0.11 0.83
Quality grade distribution, %
Prime 3.8 4.0 1.1 0.94
Upper 2/3 Choice 27.9 30.2 2.6 0.59
Low Choice 43.4 41.9 2.1 0.67
≥Low Choice 75.1 76.1 2.7 0.76
Select 23.5 23.2 1.8 0.93
Standard 1.4 0.7 0.8 0.61
aKPH = Kidney, pelvic, heart.
bMarbling score: 4.0 = Slight 00; 4.5 = Slight 50; 5.0 = Small 00; 5.5 Small 50; etc.
TABLE 10. Economic analysis of using Synovex®  Plus (Fort Dodge
Animal Health, Fort Dodge, IA) or Finaplix®-H (Intervet, Millsboro, DE),
with MGA® (melengestrol acetate; Pharmacia and Upjohn Company,
Kalamazoo, MI) supplementation as final implants in finishing heifers
(Exp. 3).
Synovex®  plus Finaplix®-H plus
Item MGA® MGA® SE P
Diet cost, $/100 kg 9.34 9.34
Cost of feed, $ per heifer 98.25 95.11 1.7 0.32
Total feeding cost,
$ per heifer 149.25 146.11 1.7 0.32
Cost of gain, $/100 kg 93.00 95.02 1.39 0.41
Carcass valuea, $/100 kg 242.58 242.80 0.81 0.87
Profitb, $ per heifer
Dressed basis 31.71 25.09 2.9 0.25
Carcass-merit basis 25.03 19.23 2.8 0.28
aCalculated using a $244/100 kg carcass base price. Discounts = $22, Select; $44,
Standard; $33, Yield Grade 4 and 5; and $66, dark cutter. Premiums = $18, Prime;
$7, upper 2/3 Choice; and $7, Yield Grades 1 and 2.
bInitial animal cost = $172/100 kg; animal returns based on $154/100 kg live price,
$244/100 kg carcass price, or calculated carcass value; interest not included.
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and the percentage of carcasses
grading USDA Choice did not differ
(P=0.17) for heifers fed MGA® and
implanted with either Synovex® Plus
or Finaplix®-H. Mader et al. (1998)
reported that marbling scores and
percentages of cattle grading USDA
Choice or above were not signifi-
cantly affected by treatments of
Synovex® Plus or 200 mg of TBA
without MGA® supplementation,
although numerically heifers im-
planted with Synovex® Plus had
lower marbling scores (5.18 vs 5.34)
and decreased percentages of heifers
grading USDA Choice or above
(51.8% vs 59.6%). Supplemental
dietary MGA® with the use of
Synovex® Plus as the final implant
tended to lessen any deleterious
effects of the implant on carcass
quality grade, as suggested by the
small change in the percentage of
USDA Choice or above carcasses
(67.2% vs 71.9%; P=0.17) and similar
marbling scores (5.47 vs 5.43; P=0.48)
compared with the implantation of
Finaplix®-H plus dietary MGA®. There
was no effect of treatment on the
percentage of Standard carcasses or
the incidence of dark cutting car-
casses.
A summary of the economic
analysis is provided in Table 4. Heifers
supplemented with MGA® had greater
(P<0.10) costs associated with feed
and total feeding compared with
those that were not supplemented
with MGA®. This increased cost is the
result of the higher ration price of
$0.16/100 kg for the MGA® -supple-
mented finishing diet. Carcass-
adjusted cost of gain was less (P<0.05)
in heifers implanted with Synovex®
Plus than in those implanted with
Finaplix®-H. Heifers implanted with
Synovex® Plus and fed MGA® re-
turned more dollars per heifer than
did heifers implanted with Finaplix®-
H and fed MGA® on a live basis price
(P<0.10); heifers implanted with
Synovex® Plus and fed no MGA®
showed an intermediate return on
dollars per heifer. On a dressed-basis
price, net return was greater (P<0.05)
when heifers were implanted with
Synovex® Plus than when implanted
with Finaplix®-H. When carcass
discounts and premiums were applied
to calculate carcass price, heifers
implanted with Synovex® Plus and
fed no MGA® had the least (P<0.01)
calculated carcass value compared
with the other two treatments.
Heifers implanted with Synovex® Plus
and fed MGA® had lesser calculated
carcass value ($/100 kg) than did
those implanted with Finaplix®-H.
However, the additive effects (gain of
efficiency) of Synovex® Plus with
supplementation of MGA® created
greater (P<0.10) carcass-merit basis net
return than that for heifers im-
planted with Synovex® Plus without
MGA® supplementation or heifers
implanted with Finaplix®-H with
MGA® supplementation by $10.97 or
$12.55 per heifer, respectively.
Experiment 2. Effects of implant
programs on performance of finish-
ing heifers implanted with Synovex®
Plus, Finaplix®-H, or Revalor®-H and
fed supplemental dietary MGA® are
presented in Table 5. Dry matter
intake was greater (P<0.05) for heifers
implanted with Synovex® Plus or
Revalor®-H compared with those
implanted with Finaplix®-H. Daily
gain, final BW, and feed efficiency
did not differ (P>0.21) among im-
plant treatments based on live weight
performance. On a carcass-adjusted
basis, heifers implanted with
Synovex® Plus as the final implant
gained 3.9 or 4.0% (P<0.10) faster
than did heifers implanted with
Revalor®-H or Finaplix®-H as the final
implant, respectively. This resulted in
heavier (P<0.05) carcass-adjusted final
weight for heifers implanted with
Synovex® Plus than for those im-
planted with Revalor®-H and
Finaplix®-H. Carcass-adjusted ADG of
TABLE 11. Effects of implant programs using Synovex®  Plus (Fort
Dodge Animal Health, Fort Dodge, IA) or Finaplix®-H (Intervet,
Millsboro, DE), with MGA® (melengestrol acetate; Pharmacia and
Upjohn Company, Kalamazoo, MI) supplementation on heifer perfor-
mance (pooled data).
Synovex®  plus Finaplix®-H plus
Item MGA® MGA® SE P
Live performanceab
Pens, no. 10 10
Heifers, no. 815 812
Days on feed 149 149
Initial BW, kg 337 349 2.2 0.49
Final BW, kg 544 541 2.6 0.22
DMI, kg/d 8.96 8.75 0.16 0.43
ADG, kg 1.44 1.40 0.02 0.09
Gain/feed 0.161 0.160 0.003 0.84
Carcass-adjusted performancec
Pens, no. 14 14
Heifers, no. 1247 1247
Days on feed 136 136
Initial BW, kg 348 349 1.8 0.55
Final BW, kg 554 547 1.7 <0.01
DMI, kg/d 9.23 9.00 0.11 0.16
ADG, kg 1.54 1.48 0.01 <0.01
Gain/feed 0.167 0.164 0.007 0.38
aFinal BW shrunk 4%.
bContains data only from Exp. 1 and 2.
cFinal BW calculated as hot carcass weight divided by 0.63 (common dressing
percentage).
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heifers implanted with Revalor®-H or
Finaplix®-H did not differ.
The results of the use of Synovex®
Plus or Revalor®-H in Experiment 2
tend to agree with Jim et al. (1998a,
b), who showed that Synovex® Plus
increased ADG by 3.3 and 5.1%,
respectively. In contrast to our
experiment, Jim et al. (1998a, b)
observed a 2.4 and 2.3% greater DMI
for heifers implanted with Synovex®
Plus than for heifers implanted with
Revalor®-H, respectively. Brandt et al.
(1996) reported a 4.6% greater ADG
for heifers implanted with Revalor®-H
and fed supplemental MGA® com-
pared with heifers implanted with
Finaplix®-H and fed supplemental
MGA®. In contrast, ADG was not
different between Revalor®-H and
Finaplix®-H in this experiment and
others (Nichols et al., 1996). Brandt
et al. (1996) and Nichols et al. (1996)
both reported that there was no
significant difference in DMI or feed
efficiency between the Revalor®-H
and Finaplix®-H and supplemented
MGA®.
Hot carcass weight was 4.4 or 5.1
kg heavier (P<0.05; Table 6) for heifers
implanted with Synovex® Plus than
for heifers implanted with Revalor®-H
or Finaplix®-H, respectively. Hot
carcass weight did not differ (P=0.67)
for heifers implanted with Revalor®-H
or Finaplix®-H. Dressing percentage
tended (P=0.13) to be different
among treatments. Longissimus area
was larger (P<0.05) for heifers im-
planted with Synovex® Plus than for
heifers implanted with Finaplix®-H;
heifers implanted with Revalor®-H
had intermediate longissimus area.
Fat thickness and KPH fat were
similar among treatments. Calculated
yield grade was similar among treat-
ments; however, the percentage of
Yield Grade 2 carcasses was greater for
heifers implanted with Finaplix®-H
than for  heifers implanted with
Revalor®-H; heifers implanted with
Synovex® Plus had intermediate
percentages of Yield Grade 2 carcasses.
Marbling score was less (P<0.10) for
heifers implanted with Synovex® Plus
than for those implanted with either
Revalor®-H or Finaplix®-H. Heifers
implanted with Revalor-H had a
lower (P<0.10) marbling score than
heifers implanted with Finaplix®-H.
The percentage of carcasses grading
upper 2/3 USDA Choice was less
(P<0.05) and the percentage of
carcasses grading USDA Select was
greater (P<0.10) for heifers implanted
with Synovex® Plus in comparison
with those implanted with Revalor®-
H or Finaplix®-H. The percentage of
carcasses grading USDA Standard and
the incidence of dark cutting car-
casses did not differ (P>0.18) among
treatments.
Jim et al. (1998a, b) reported the
percentage of heifers grading USDA
Choice or above was not significantly
different between heifers implanted
with Synovex® Plus and those im-
planted with Revalor®-H. In the
studies of Jim et al. (1998a, b), days
heifers were exposed to the final
implant were greater (115 vs 95 d)
than in this study, which might have
affected marbling score and percent-
age of heifers grading USDA Choice
or above. Increasing the days heifers
are exposed to the final implant
before harvest may decrease the
difference in quality grade.
A summary of the economic
analysis is provided in Table 7. Cost
of gain was similar among treat-
ments. Cost of feed and total feeding
costs were (P<0.05) less for heifers
implanted with Finaplix®-H than for
heifers implanted with Synovex® Plus
or Revalor®-H, which is due to the
decreased DMI by Finaplix®-H im-
planted heifers. Carcass value, figured
on individual carcasses for premiums
and discounts, for heifers implanted
with Finaplix®-H were greater (P<0.05)
TABLE 12. Effects of implant programs using Synovex®  Plus (Fort
Dodge Animal Health, Fort Dodge, IA) or Finaplix®-H (Intervet,
Millsboro, DE), with MGA® (melengestrol acetate; Pharmacia and Upjohn
Company, Kalamazoo, MI) supplementation on heifer carcass character-
istics (pooled data).
Synovex®  plus Finaplix®-H plus
Item MGA® MGA® SE P
Hot carcass weight, kg 349 345 1.1 <0.01
Dressing percentagea 65.0 64.5 0.1 <0.01
Fat thickness, cm 1.37 1.35 0.03 0.54
Longissimus area, cm2 90.9 88.2 0.8 <0.01
KPHb fat, % 2.21 2.23 0.02 0.48
Calculated yield grade 2.70 2.78 0.06 0.23
Yield grade distribution, %
1 18.5 14.7 3.3 0.27
2 46.0 48.3 2.9 0.44
3 29.8 30.9 2.6 0.70
4 and 5 5.6 6.1 1.1 0.68
Marbling scorec 5.42 5.50 0.08 0.42
Quality grade distribution, %
Prime 2.9 2.4 1.0 0.66
Upper 2/3 Choice 20.2 23.4 1.8 0.38
Low Choice 40.7 45.0 2.8 0.15
≥Low Choice 63.9 70.7 3.4 0.18
Select 34.3 28.3 3.0 0.19
Standard 1.9 0.9 0.6 0.12
Dark cutters, % 0.8 0.0 0.4 0.06
aContains data only from Exp. 1 and 2.
bKPH = Kidney, pelvic, heart.
cMarbling score: 4.0 = Slight 00, 4.5 = Slight 50, 5.0 = Small 00, 5.5 Small 50, etc.
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than those for those heifers im-
planted with Synovex® Plus; Revalor®-
H-implanted heifers had intermediate
carcass values. Net return on a
dressed-basis value tended (P=0.15) to
be $10.49 greater per heifer for heifers
implanted with Synovex® Plus than
for heifers implanted with Revalor®-
H.
Experiment 3. Effects of implant
program on performance of finishing
heifers that were implanted with
Synovex® Plus or Finaplix®-H and fed
supplemental MGA® are presented in
Table 8. Dry matter intake did not
differ (P=0.32) between the implant
strategies. Heifers implanted with
Synovex® Plus gained 4.2% (P=0.02)
faster than those implanted with
Finaplix®-H. This resulted in 8-kg
heavier (P=0.09) carcass-adjusted final
weights. Feed efficiency did not differ
(P=0.85) between implant strategies.
Hot carcass weight was 5 kg heavier
(P=0.09; Table 9), and longissimus
area was 1.3% larger (P=0.10), for
heifers implanted with Synovex® Plus
compared with heifers implanted
with Finaplix®-H. Calculated yield
grade, fat thickness, and marbling
score did not differ (P>0.76) between
heifers implanted with Synovex® Plus
or Finaplix®-H. Additionally, the
distribution of USDA quality grade
and calculated yield grade did not
differ between implant treatments.
All economic variables measured did
not differ (P>0.25) between implant
treatments (Table 10).
Pooled Data. Effects of Synovex®
Plus and supplement with MGA®
compared with Finaplix®-H and
supplemental MGA® on finishing
heifer performance across three
experiments are summarized in Table
11 (14 pens per treatment). Only data
from Experiments 1 and 2 were
pooled for performance on a live
basis, because in Experiment 3, final
live BW were not recorded. Initial BW
averaged 348 kg for 2,494 heifers. On
a live basis, ADG was 2.8% greater
(P<0.10) for heifers implanted with
Synovex® Plus than for heifers
implanted with Finaplix®-H. Carcass-
adjusted ADG was 4.4% greater
(P<0.01) for heifers that received
Synovex® Plus implants than for
those that received Finaplix®-H
implants, which resulted in carcass-
adjusted final BW that were 7.4 kg
heavier (P<0.01) for heifers implanted
with Synovex® Plus than for heifers
implanted with Finaplix®-H. Dry
matter intake tended to be increased
by 2.7% (P=0.16) for those heifers
receiving Synovex® Plus implants
compared with those receiving
Finaplix®-H implants; feed efficiencies
were similar between treatments. On
a live basis, final BW and feed
efficiency did not differ between
treatments.
Carcass characteristics for pooled
data are presented in Table 12. Heifers
implanted with Synovex® Plus had
4.7 kg heavier (P<0.01) carcasses
compared with heifers implanted
with Finaplix®-H. Dressing percentage
was 0.5% units greater (P<0.01) for
heifers implanted with Synovex® Plus
(65.0%) than for heifers implanted
with Finaplix®-H (64.5%). Calculated
yield grade, fat thickness, and KPH
fat did not differ between treatments.
Longissimus area was larger (P<0.01)
for heifers implanted with Synovex®
Plus than for heifers implanted with
Finaplix®-H. The percentage of
carcasses grading USDA Low Choice
or greater tended to be greater
(P=0.18) for heifers implanted with
Finaplix®-H than for those implanted
with Synovex® Plus, although mar-
bling score was not affected (P=0.42)
by treatments. The distribution of
calculated yield grade was similar
between treatments. The incidence of
dark cutting was greater (P<0.10) for
heifers implanted with Synovex® Plus
than for heifers implanted with
Finaplix®-H.
A summary of the economic
pooled data is presented in Table 13.
Live cost of gain, carcass-adjusted cost
of gain, feeding cost, carcass value,
and carcass-merit net return were
similar between treatments. Dressed
basis net return tended to be in-
TABLE 13. Economic analysis of using Synovex®  Plus (Fort Dodge
Animal Health, Fort Dodge, IA) or Finaplix®-H (Intervet, Millsboro, DE),
with MGA® (melengestrol acetate; Pharmacia and Upjohn Company,
Kalamazoo, MI) supplementation as final implants in finishing heifers
(pooled data).
Synovex®  plus Finaplix®-H plus
Item MGA® MGA® SE P
Cost of feed, $ per heifer 158.43 154.72 2.17 0.21
Total feeding cost,
$ per heifer 182.11 178.23 1.98 0.17
Live cost of gain,
$/100 kga 95.09 95.46 1.70 0.86
Carcass-adjusted cost
of gain, $/100 kg 89.32 91.26 1.12 0.21
Carcass value, $/100 kgb 239.58 241.92 1.21 0.19
Profit, $ per heiferc
Live basisa 58.60 50.77 7.19 0.47
Dressed basis 71.86 62.06 3.78 0.11
Carcass-merit basis 57.57 55.41 7.42 0.80
aContains data from only Exp. 1 and 2.
bCalculated using a $244/100 kg carcass base price. Discounts = $22, Select; $44,
Standard; $33, Yield Grade 4 and 5; and $66, dark cutter. Premiums = $18, Prime;
$7, upper 2/3 Choice; and $7, Yield Grades 1 and 2.
cInitial animal cost = $172/100 kg; animal returns based on $154/100 kg live price,
$244/100 kg carcass price, or calculated carcass value; interest not included.
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creased (P=0.11) by $9.80 per heifer
for heifers implanted with Synovex®
Plus compared with those implanted
with Finaplix®-H.
Implications
Implanting finishing heifers with
Synovex® Plus as a final implant in
combination with supplemental
dietary MGA® increased ADG and
carcass weight. However, there ap-
pears to be some reduction in per-
centage of carcasses grading USDA
Choice when comparing heifers
implanted with Synovex® Plus with
those implanted with Revalor®-H or
Finaplix®-H and fed MGA®. Feedlot
performance was enhanced and
offset any economic losses caused by
a decrease in carcasses grading Choice
when using Synovex® Plus and MGA®
relative to the other implant regi-
mens. The Choice–Select spread
would need to be >$22/100 kg ($10/
cwt) of carcass weight before im-
proved performance would be ne-
gated when using Synovex® Plus and
MGA®. Clearly, feedlot performance
has major implications on economic
returns for the various implant
regimens.
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